TC Medical's 1H 2020 Revenue Totals CNY 738 Mn, Down 12.87% YoY
TC Medical released its financial report for 1H 2020, showing that the company earned revenue of CNY 738 million, down 12.87% year-on-year; net profit of CNY 145 million, down 30.22% year-on-year.
This text is a result of machine translation.
Related companies：
Briefing Jun 24, 2022 11:15 AM
· Healthcare
F-star to be acquired by China biopharmaceutical with USD 161million
In-depth
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Aug 29, 2022 05:45 PM
Research
Healthcare, Technology, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Dec 09, 2020 09:57 AM
Briefing Oct 19, 2021 06:56 AM
· Financials
The investment banking business was strictly supervised, and seven securities companies received fines
Healthcare
Cellatopia Secures Nearly CNY Ten Mn in Seed Funding
EqualOcean has learned that Cellatopia(喜同生物), a biotechnology company based in Suzhou, recently announced the successful securing of nearly CNY ten million in seed funding. The funding was primarily led by Suzhou Shishangbai Venture Capital(苏州石上柏创业合伙企业) and followed by institutions such as Suzhou Nuowei Venture Investment Limited(苏州诺为创业投资有限公司).
Yesterday 01:25 PM
Briefing Oct 17, 2021 06:26 PM
· Healthcare
The first batch of "Mao" concept achievements were released, with a year-on-year growth of more than 50%
Briefing Oct 15, 2021 06:25 PM
· Healthcare
Wantai biology: it is proposed to raise no more than 3.5 billion yuan for the phase II expansion project of nine price cervical cancer vaccine
Briefing Sep 17, 2021 11:58 AM
· Technology
Amazon: the policy is consistent all over the world, and the title is not for Chinese businesses
Briefing Jul 20, 2021 01:18 AM
· Consumer Staples
Zhang Kun's four funds decreased their positions in the second quarter by allocating Wuliangye to Guizhou Maotai
See more
Read next
Insight
In-depth
Insight
In-depth